Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf Conversion in Stable Liver Transplant Recipients
NCT04763096Phase 4Completed
- Sponsor
- Linical
- Start
- Nov 2016
- Primary completion
- Apr 2020
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in Liver transplant rejection, sponsored by Linical. Started Nov 2016; status: completed.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT04763096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04763096.